Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study

por Cornberg, Markus, Ahumada, Adriana, Aghemo, Alessio, Andreoni, Massimo, Bhagat, Abhi, Butrymowicz, Isabel, Carmiel, Michal, Chodick, Gabriel, Conway, Brian, Song, Yanna, Gasbarrini, Antonio, Hüppe, Dietrich, Plaza, Francisco Jorquera, Lampertico, Pietro, Alonso, Maria Luisa Manzano, Myles, Lindsay, Persico, Marcello, Ramji, Alnoor, Sarrazin, Christoph, Villa, Erica, Weil, Clara, Otano, Juan Isidro Uriz
Publicado 2022